Sign in
Not yet recruitingPhase 1

A randomized, placebo-controlled, single-blind phase 1 trial to evaluate safety, pharmacokinetics and pharmacodynamics of subcutaneously administered RBD3133 in healthy participants with overweight/obesity

Key facts

Who runs it
Ribocure Pharmaceuticals AB
Where
Sweden1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 1
People taking part
80 people, planned
Starts
14 Dec 2026
Expected to end
31 Dec 2027
Type of study
Interventional
Record updated
13 November 2026

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Can take part

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Criteria questions
Built from 2026-525607-27-00, who can take part
Record updated
13 November 2026